Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?
Sciarra A, Santarelli V, Santodirocco L, Frisenda M, Salciccia S, Casale P, Forte F, Mariotti G, Moriconi M, Cattarino S, Sciarra B, Bevilacqua G, Gentilucci A. Sciarra A, et al. Among authors: bevilacqua g. Curr Oncol. 2023 Aug 30;30(9):8054-8067. doi: 10.3390/curroncol30090584. Curr Oncol. 2023. PMID: 37754499 Free PMC article. Review.
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project.
Hurle R, Casale P, Saita A, Colombo P, Elefante GM, Lughezzani G, Fasulo V, Paciotti M, Domanico L, Bevilacqua G, Maffei D, Diana P, Frego N, Sandri MT, Maura F, Morenghi E, Buffi NM, Guazzoni G, Lazzeri M. Hurle R, et al. Among authors: bevilacqua g. World J Urol. 2020 Sep;38(9):2215-2220. doi: 10.1007/s00345-019-03002-3. Epub 2019 Nov 5. World J Urol. 2020. PMID: 31691083
Prospective Evaluation of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer Diagnosis.
Lopci E, Lughezzani G, Castello A, Saita A, Colombo P, Hurle R, Peschechera R, Benetti A, Zandegiacomo S, Pasini L, Casale P, Pietro D, Bevilacqua G, Balzarini L, Buffi NM, Guazzoni G, Lazzeri M. Lopci E, et al. Among authors: bevilacqua g. Eur Urol Focus. 2021 Jul;7(4):764-771. doi: 10.1016/j.euf.2020.03.004. Epub 2020 Apr 17. Eur Urol Focus. 2021. PMID: 32312701
How to Predict Outcomes from a Biofeedback and Pelvic Floor Muscle Electric Stimulation Program in Patients with Urinary Incontinence after Radical Prostatectomy.
Salciccia S, Sciarra A, Moriconi M, Maggi M, Viscuso P, Rosati D, Frisenda M, Di Pierro GB, Canale V, Bevilacqua G, Nesi G, Del Giudice F, Gentilucci A, Cattarino S, Mariotti G. Salciccia S, et al. Among authors: bevilacqua g. J Clin Med. 2021 Dec 27;11(1):127. doi: 10.3390/jcm11010127. J Clin Med. 2021. PMID: 35011866 Free PMC article.
Comment on: "Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis".
Salciccia S, Sciarra A, Cattarino S, Mariotti G, Bevilacqua G, Gentilucci A. Salciccia S, et al. Among authors: bevilacqua g. Minerva Urol Nephrol. 2022 Jun;74(3):360-362. doi: 10.23736/S2724-6051.22.04948-5. Minerva Urol Nephrol. 2022. PMID: 35607782 Free article. No abstract available.
Regenerative Medicine-Based Treatment of Stress Urinary Incontinence with Mesenchymal Stem Cells: A Systematic Review and Meta-analysis.
Mariotti G, Salciccia S, Viscuso P, Bevilacqua G, Casale P, Frisenda M, Di Pierro GB, Cattarino S, Gentilucci A, Rosati D, Sciarra B, Sciarra A. Mariotti G, et al. Among authors: bevilacqua g. Curr Stem Cell Res Ther. 2023;18(3):429-437. doi: 10.2174/1574888X17666220616100621. Curr Stem Cell Res Ther. 2023. PMID: 35713128
Comparison of Different Invasive Devices for the Treatment of Urinary Incontinence after Radical Prostatectomy.
Salciccia S, Viscuso P, Bevilacqua G, Tufano A, Casale P, De Berardinis E, Di Pierro GB, Cattarino S, Gentilucci A, Lourdes Lia F, Ivan DG, Rosati D, Del Giudice F, Sciarra A, Mariotti G. Salciccia S, et al. Among authors: bevilacqua g. Adv Urol. 2022 Jun 21;2022:8736249. doi: 10.1155/2022/8736249. eCollection 2022. Adv Urol. 2022. PMID: 35774194 Free PMC article. Review.
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review.
Salciccia S, Frisenda M, Bevilacqua G, Viscuso P, Casale P, De Berardinis E, Di Pierro GB, Cattarino S, Giorgino G, Rosati D, Del Giudice F, Sciarra A, Mariotti G, Gentilucci A. Salciccia S, et al. Among authors: bevilacqua g. Int J Mol Sci. 2022 Sep 29;23(19):11501. doi: 10.3390/ijms231911501. Int J Mol Sci. 2022. PMID: 36232828 Free PMC article. Review.
Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic Prostate Cancer.
Salciccia S, Frisenda M, Bevilacqua G, Viscuso P, Casale P, De Berardinis E, Di Pierro GB, Cattarino S, Giorgino G, Rosati D, Del Giudice F, Carbone A, Pastore A, Chung BI, Eisenberg ML, Autorino R, Crivellaro S, Forte F, Sciarra A, Mariotti G, Gentilucci A. Salciccia S, et al. Among authors: bevilacqua g. Curr Oncol. 2022 Dec 3;29(12):9474-9500. doi: 10.3390/curroncol29120745. Curr Oncol. 2022. PMID: 36547159 Free PMC article.
How the Analysis of the Pathogenetic Variants of DDR Genes Will Change the Management of Prostate Cancer Patients.
Sciarra A, Frisenda M, Bevilacqua G, Gentilucci A, Cattarino S, Mariotti G, Del Giudice F, Di Pierro GB, Viscuso P, Casale P, Chung BI, Autorino R, Crivellaro S, Salciccia S. Sciarra A, et al. Among authors: bevilacqua g. Int J Mol Sci. 2022 Dec 30;24(1):674. doi: 10.3390/ijms24010674. Int J Mol Sci. 2022. PMID: 36614122 Free PMC article. Review.
441 results